Evidence map›Paper›PMID 26696807›Full record

ArticleFrontiers in neuroscience2015

The Basal NPO crh Fluctuation is Sustained Under Compromised Glucocorticoid Signaling in Diurnal Zebrafish.

Chen-Min Yeh

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Chen-Min YehDevelopmental Genetics of the Nervous System, Max Planck Institute for Medical Research Heidelberg, Germany.
Max Planck Institute for Medical Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The circadian activity of the hypothalamo-pituitary-adrenal/interrenal (HPA/I) axis is crucial for maintaining vertebrate homeostasis. In mammals, both the principle regulator, corticotropin-releasing hormone (crh) in the hypothalamic paraventricular nucleus (PVN) and the final effector, the glucocorticoids show daily rhythmic patterns. While glucocorticoids are the main negative regulator of PVN crh under stress, whether they modulate the PVN crh rhythm under basal condition is unclear in diurnal animals. Using zebrafish larvae, a recently-established diurnal model organism suited for the HPA/I axis and homeostasis research, we ask if glucocorticoid changes are required to maintain the daily variation of PVN crh. We first characterized the development of the HPI axis overtime and showed that the basal activity of the HPI axis is robust and tightly regulated by circadian cue in 6-day old larvae. We demonstrated a negative correlation between the basal cortisol and neurosecretory preoptic area (NPO) crh variations. To test if cortisol drives NPO crh variation, we analyzed the NPO crh levels in glucorcorticoid antagonist-treated larvae and mutants lacking circadian cortisol variations. We showed that NPO crh basal fluctuation is sustained although the level was decreased without proper cortisol signaling in zebrafish. Our data indicates that glucocorticoids do not modulate the basal NPO crh variations but may be required for maintaining overall NPO crh levels. This further suggests that under basal and stress conditions the HPA/I axis activity is modulated differently by glucocorticoids.

Indexed as

circadian variationcorticortropin-releasing hormonecortisoldiurnal zebrafish larvanegative feedbackneurosecretory preoptic areathe hypothalamo-pituitary-adrenal/interrenal axis

Identifiers

PMID26696807
PMCPMC4667085
OpenAlexW2181473817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.